Correction: Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy

Hui Wang^#^{1

2}, Timothy S Chang^#³, Beth A Dombroski^{1

2}, Po-Liang Cheng^{1

2}, Vishakha Patil³, Leopoldo Valiente-Banuet³, Kurt Farrell⁴, Catriona Mclean⁵, Laura Molina-Porcel^{6

7}, Alex Rajput⁸, Peter Paul De Deyn^{9

10}, Nathalie Le Bastard¹¹, Marla Gearing¹², Laura Donker Kaat¹³, John C Van Swieten¹³, Elise Dopper¹³, Bernardino F Ghetti¹⁴, Kathy L Newell¹⁴, Claire Troakes¹⁵, Justo G de Yébenes¹⁶, Alberto Rábano-Gutierrez¹⁷, Tina Meller¹⁸, Wolfgang H Oertel¹⁸, Gesine Respondek¹⁹, Maria Stamelou^{20

21}, Thomas Arzberger^{22

23}, Sigrun Roeber²⁴, Ulrich Müller²⁴, Franziska Hopfner²⁵, Pau Pastor^{26

27}, Alexis Brice²⁸, Alexandra Durr²⁸, Isabelle Le Ber²⁸, Thomas G Beach²⁹, Geidy E Serrano²⁹, Lili-Naz Hazrati³⁰, Irene Litvan³¹, Rosa Rademakers^{32

33}, Owen A Ross³³, Douglas Galasko³¹, Adam L Boxer³⁴, Bruce L Miller³⁴, Willian W Seeley³⁴, Vivanna M Van Deerlin¹, Edward B Lee^{1

35}, Charles L White 3rd³⁶, Huw Morris³⁷, Rohan de Silva³⁸, John F Crary⁴, Alison M Goate³⁹, Jeffrey S Friedman⁴⁰, Yuk Yee Leung^{1

2}, Giovanni Coppola^{3

41}, Adam C Naj^{1

2

42}, Li-San Wang^{1

2}; P. S. P. genetics study group; Clifton Dalgard⁴³, Dennis W Dickson⁴⁴, Günter U Höglinger⁴⁵, Gerard D Schellenberg^{46

47}, Daniel H Geschwind^{48

49

50}, Wan-Ping Lee^{51

52}

Affiliations

¹ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
² Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
³ Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
⁴ Department of Pathology, Department of Artificial Intelligence & Human Health, Nash Family, Department of Neuroscience, Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain, Institute, Neuropathology Brain Bank & Research CoRE, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁵ Victorian Brain Bank, The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
⁶ Alzheimer's Disease and Other Cognitive Disorders Unit. Neurology Service, Hospital Clínic, Fundació Recerca Clínic Barcelona (FRCB). Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
⁷ Neurological Tissue Bank of the Biobanc-Hospital Clínic-IDIBAPS, Barcelona, Spain.
⁸ Movement Disorders Program, Division of Neurology, University of Saskatchewan, Saskatoon, SK, Canada.
⁹ Laboratory of Neurochemistry and Behavior, Experimental Neurobiology Unit, University of Antwerp, Wilrijk (Antwerp), Belgium.
¹⁰ Department of Neurology, University Medical Center Groningen, NL-9713 AV, Groningen, Netherlands.
¹¹ Fujirebio Europe NV, Technologiepark 6, 9052, Ghent, Belgium.
¹² Department of Pathology and Laboratory Medicine and Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
¹³ Netherlands Brain Bank and Erasmus University, Rotterdam, Netherlands.
¹⁴ Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
¹⁵ London Neurodegenerative Diseases Brain Bank, King's College London, London, UK.
¹⁶ Autonomous University of Madrid, Madrid, Spain.
¹⁷ Fundación CIEN (Centro de Investigación de Enfermedades Neurológicas) - Centro Alzheimer Fundación Reina Sofía, Madrid, Spain.
¹⁸ Department of Neurology, Philipps-Universität, Marburg, Germany.
¹⁹ German Center for Neurodegenerative Diseases (DZNE), Marburg, Germany.
²⁰ Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital, Athens, Greece.
²¹ European University of Cyprus, Nicosia, Cyprus.
²² Department of Psychiatry and Psychotherapy, University Hospital Munich, Ludwig-Maximilians-University Munich, Munich, Germany.
²³ Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany.
²⁴ Institute of Human Genetics, Justus-Liebig University Giessen, 35392, Giessen, Germany.
²⁵ Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
²⁶ Unit of Neurodegenerative Diseases, Department of Neurology, University Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain.
²⁷ Neurosciences, The Germans Trias I Pujol Research Institute (IGTP) Badalona, Barcelona, Spain.
²⁸ Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, APHP - Hôpital Pitié-Salpêtrière, Paris, France.
²⁹ Banner Sun Health Research Institute, Sun City, AZ, USA.
³⁰ University McGill, Montreal, QC, Canada.
³¹ Department of Neuroscience, University of California, San Diego, CA, USA.
³² VIB Center for Molecular Neurology, University of Antwerp, Antwerp, Belgium.
³³ Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, FL, USA.
³⁴ Memory and Aging Center, University of California, San Francisco, CA, USA.
³⁵ Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
³⁶ University of Texas Southwestern Medical Center, Dallas, TX, USA.
³⁷ Departmento of Clinical and Movement Neuroscience, University College of London, London, UK.
³⁸ Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK.
³⁹ Department of Genetics and Genomic Sciences, New York, NY, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁴⁰ Friedman Bioventure, Inc., Del Mar, CA, USA.
⁴¹ Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
⁴² Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁴³ Department of Anatomy Physiology and Genetics, the American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
⁴⁴ Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, FL, USA. Dickson.Dennis@mayo.edu.
⁴⁵ Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. guenter.hoeglinger@med.uni-muenchen.de.
⁴⁶ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. gerardsc@pennmedicine.upenn.edu.
⁴⁷ Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. gerardsc@pennmedicine.upenn.edu.
⁴⁸ Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. dhg@mednet.ucla.edu44.
⁴⁹ Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. dhg@mednet.ucla.edu44.
⁵⁰ Institute of Precision Health, University of California, Los Angeles, Los Angeles, CA, USA. dhg@mednet.ucla.edu44.
⁵¹ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. wan-ping.lee@pennmedicine.upenn.edu.
⁵² Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. wan-ping.lee@pennmedicine.upenn.edu.

^# Contributed equally.

PMID: 39402686
PMCID: PMC11475913
DOI: 10.1186/s13024-024-00763-3

Published Erratum

Correction: Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy

Hui Wang et al. Mol Neurodegener. 2024.

. 2024 Oct 14;19(1):73.

doi: 10.1186/s13024-024-00763-3.

Authors

Affiliations

¹ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
² Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
³ Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
⁴ Department of Pathology, Department of Artificial Intelligence & Human Health, Nash Family, Department of Neuroscience, Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain, Institute, Neuropathology Brain Bank & Research CoRE, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁵ Victorian Brain Bank, The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
⁶ Alzheimer's Disease and Other Cognitive Disorders Unit. Neurology Service, Hospital Clínic, Fundació Recerca Clínic Barcelona (FRCB). Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
⁷ Neurological Tissue Bank of the Biobanc-Hospital Clínic-IDIBAPS, Barcelona, Spain.
⁸ Movement Disorders Program, Division of Neurology, University of Saskatchewan, Saskatoon, SK, Canada.
⁹ Laboratory of Neurochemistry and Behavior, Experimental Neurobiology Unit, University of Antwerp, Wilrijk (Antwerp), Belgium.
¹⁰ Department of Neurology, University Medical Center Groningen, NL-9713 AV, Groningen, Netherlands.
¹¹ Fujirebio Europe NV, Technologiepark 6, 9052, Ghent, Belgium.
¹² Department of Pathology and Laboratory Medicine and Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
¹³ Netherlands Brain Bank and Erasmus University, Rotterdam, Netherlands.
¹⁴ Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
¹⁵ London Neurodegenerative Diseases Brain Bank, King's College London, London, UK.
¹⁶ Autonomous University of Madrid, Madrid, Spain.
¹⁷ Fundación CIEN (Centro de Investigación de Enfermedades Neurológicas) - Centro Alzheimer Fundación Reina Sofía, Madrid, Spain.
¹⁸ Department of Neurology, Philipps-Universität, Marburg, Germany.
¹⁹ German Center for Neurodegenerative Diseases (DZNE), Marburg, Germany.
²⁰ Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital, Athens, Greece.
²¹ European University of Cyprus, Nicosia, Cyprus.
²² Department of Psychiatry and Psychotherapy, University Hospital Munich, Ludwig-Maximilians-University Munich, Munich, Germany.
²³ Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany.
²⁴ Institute of Human Genetics, Justus-Liebig University Giessen, 35392, Giessen, Germany.
²⁵ Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
²⁶ Unit of Neurodegenerative Diseases, Department of Neurology, University Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain.
²⁷ Neurosciences, The Germans Trias I Pujol Research Institute (IGTP) Badalona, Barcelona, Spain.
²⁸ Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, APHP - Hôpital Pitié-Salpêtrière, Paris, France.
²⁹ Banner Sun Health Research Institute, Sun City, AZ, USA.
³⁰ University McGill, Montreal, QC, Canada.
³¹ Department of Neuroscience, University of California, San Diego, CA, USA.
³² VIB Center for Molecular Neurology, University of Antwerp, Antwerp, Belgium.
³³ Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, FL, USA.
³⁴ Memory and Aging Center, University of California, San Francisco, CA, USA.
³⁵ Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
³⁶ University of Texas Southwestern Medical Center, Dallas, TX, USA.
³⁷ Departmento of Clinical and Movement Neuroscience, University College of London, London, UK.
³⁸ Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK.
³⁹ Department of Genetics and Genomic Sciences, New York, NY, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁴⁰ Friedman Bioventure, Inc., Del Mar, CA, USA.
⁴¹ Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
⁴² Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁴³ Department of Anatomy Physiology and Genetics, the American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
⁴⁴ Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, FL, USA. Dickson.Dennis@mayo.edu.
⁴⁵ Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. guenter.hoeglinger@med.uni-muenchen.de.
⁴⁶ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. gerardsc@pennmedicine.upenn.edu.
⁴⁷ Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. gerardsc@pennmedicine.upenn.edu.
⁴⁸ Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. dhg@mednet.ucla.edu44.
⁴⁹ Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. dhg@mednet.ucla.edu44.
⁵⁰ Institute of Precision Health, University of California, Los Angeles, Los Angeles, CA, USA. dhg@mednet.ucla.edu44.
⁵¹ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. wan-ping.lee@pennmedicine.upenn.edu.
⁵² Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. wan-ping.lee@pennmedicine.upenn.edu.

^# Contributed equally.

PMID: 39402686
PMCID: PMC11475913
DOI: 10.1186/s13024-024-00763-3

No abstract available

PubMed Disclaimer

Erratum for

Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy.
Wang H, Chang TS, Dombroski BA, Cheng PL, Patil V, Valiente-Banuet L, Farrell K, Mclean C, Molina-Porcel L, Rajput A, De Deyn PP, Le Bastard N, Gearing M, Kaat LD, Van Swieten JC, Dopper E, Ghetti BF, Newell KL, Troakes C, de Yébenes JG, Rábano-Gutierrez A, Meller T, Oertel WH, Respondek G, Stamelou M, Arzberger T, Roeber S, Müller U, Hopfner F, Pastor P, Brice A, Durr A, Le Ber I, Beach TG, Serrano GE, Hazrati LN, Litvan I, Rademakers R, Ross OA, Galasko D, Boxer AL, Miller BL, Seeley WW, Van Deerlin VM, Lee EB, White CL 3rd, Morris H, de Silva R, Crary JF, Goate AM, Friedman JS, Leung YY, Coppola G, Naj AC, Wang LS; P. S. P. genetics study group; Dalgard C, Dickson DW, Höglinger GU, Schellenberg GD, Geschwind DH, Lee WP. Wang H, et al. Mol Neurodegener. 2024 Aug 16;19(1):61. doi: 10.1186/s13024-024-00747-3. Mol Neurodegener. 2024. PMID: 39152475 Free PMC article.

References

1. Wang H, Chang TS, Dombroski BA, et al. Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy. Mol Neurodegeneration. 2024;19:61. 10.1186/s13024-024-00747-3. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy

Affiliations

Correction: Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy

Authors

Affiliations

Erratum for

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources